About

Bophas Groep, formed by the merger of Farmazorg and Bophas and based in Belgium, provides healthcare solutions via Individual Medication Preparation, Unit Dose Dispensing, and medical aids delivery. Its digital supply chain and smart platform boost safety, efficiency, and affordability, addressing staff shortages, aging populations, and rising care demands.

farmazorg.com

Supporting VCP-Partner
Stijn Nauts
stijn@vybros.be
+32 471 22 52 68

Status

Active

Entry

2023

Type

Direct Investment

Investment theme

Health and wellbeing

Value creation strategy

Vybros Capital Partners strategically supports the Bophas Groep in growth, professionalization, and long-term value creation. Facing major challenges such as an aging population, staffing shortages, and the need for affordable care, innovation and efficiency are vital in healthcare. To address this, Bophas (Bofar, Bmedi and Ultimedi) and Farmazorg (Farmazorg and Farmadistri) merged into Bophas Group, combining complementary expertise and a fully digitized chain to offer safer, more efficient, and future-proof solutions for patients.

Farmazorg specializes in Individual Medication Preparation (IMP) for care homes and institutions, while Bophas provides customized medical devices for pharmacies, care centers, and home nurses. The group aims to further expand through implementing strategic capex programs as well as mergers and acquisitions, strengthening its position as a leading healthcare provider.